latest update:
[TrialBase DB]

trial summary · NCT06988319

Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study

Trial record from the TrialBase DB dataset, status RECRUITING, condition Chronic Pelvic Pain, sponsored by Oregon Health and Science University. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT06988319phase PHASE1enrollment 15start 2026-11-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The primary aim is to determine the feasibility of enrolling and 15 women with chronic pelvic pain (CPP) that have failed one conventional for CPP to obtain preliminary safety data on a single administration of a moderate dose of pharmaceutical grade psilocybin (25 mg) in combination with psychotherapy sessions (two pre-dose preparatory and three post-dose integration sessions).

Source record: https://clinicaltrials.gov/study/NCT06988319

Facts

registry idNCT06988319
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionChronic Pelvic Pain
sponsorOregon Health and Science University
sponsor classOTHER
enrollment15
start date2026-11-01
primary completion2027-12-31
completion2027-12-31
results postednot reported

Conditions

  • Chronic Pelvic Pain

Interventions

  • Psilocybin (Usona Institute)

Countries

  • United States

Intervention types: DRUG

Work with this record